Back to Results
First PageMeta Content
Pharmacokinetics / Pharmacodynamics / Clinical pharmacology / Clinical trial / Simulation / Food and Drug Administration / Drug development / PK/PD models / Pharmaceutical sciences / Pharmacology / Clinical research


Description of the Particular Matter to Which the Waiver Applies: The committee will discuss the clinical pharmacology aspects of pediatric clinical trial design and dosing to optimize pediatric drug development. FDA wi
Add to Reading List

Open Document

File Size: 252,15 KB

Share Result on Facebook

Company

Drug Evaluation and Research / /

Facility

University of Pennsylvania / The Children’s Hospital of Philadelphia / /

MedicalCondition

disease / /

Organization

FDA / Center for Drug Evaluation and Research / Pediatric Pharmacology Research Unit / Food and Drug Administration / University of Pennsylvania / Children’s Hospital of Philadelphia / office of Clinical Pharmacology / Laboratory for Applied PK/PD / /

Person

Jeffrey Barrett / Pediatric Pharmacology / /

Position

Associate Professor of Pediatrics / Director and Principal Investigator / Director / /

ProvinceOrState

Pennsylvania / /

Technology

pharmacokinetics / pharmacodynamics / simulation / drug development / /

SocialTag